Among these ligands, heparin-binding EGF-like growth factor (HBEGF) is a well-documented biomarker for many types of cancer, including lung cancer18, mucoepidermoid carcinoma19, and pancreatic cancer20, and is expressed at high levels in macrophages21–23. This evidence concerns the gene HBEGF and cancer.